Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.

导出 LinkOut

翻译打印收藏纠错

作者： Marco,Galluzzo ^[1] ; Marina,Talamonti ^[1] ; Laura,Atzori ^[2] ; Federico,Bardazzi ^[3] ; Anna,Campanati ^[4] ; Antonella,Di Cesare ^[5] ; Federico,Diotallevi ^[4] ; Maria Laura,Flori ^[6] ; Cristina,Mugheddu ^[2] ; Annamaria,Offidani ^[4] ; Stefano,Piaserico ^[7] ; Filomena,Russo ^[6] ; Lidia,Sacchelli ^[3] ; Luca,Bianchi ^[1] ; Francesca,Prignano ^[5]

作者单位： Dermatology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy. ^[1] Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. ^[2] Dermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy. ^[3] Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy. ^[4] Dermatology Clinic, Department of Health Sciences, University of Florence, Florence, Italy. ^[5] Dermatology Section, Department of Medical, Surgical and Neurological Science, University of Siena, S. Maria Alle Scotte Hospital, Siena, Italy. ^[6] Dermatology Unit - Department of Medicine, University of Padova, Padova, Italy. ^[7]

关键词 Effectiveness observational palmoplantar psoriasis psoriasis real-life real-world secukinumab

主题词人类(Humans);银屑病(Psoriasis);回顾性研究(Retrospective Studies);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)

DOI 10.1080/14712598.2022.2029841

PMID 35043741

发布时间 2022-04-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交